3 Einträge gefunden

1. De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial

   1. Gluz, Oleg
   2. Nitz, Ulrike
   3. Kolberg-Liedtke, Cornelia
   4. Prat, Aleix
   5. Christgen, Matthias
   6. Kuemmel, Sherko
   7. Mohammadian, Mohammad Parsa

   2022 - Forschungsinformationssystem des UKE
2. De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial

   1. Nitz, Ulrike
   2. Gluz, Oleg
   3. Graeser, Monika
   4. Christgen, Matthias
   5. Kuemmel, Sherko
   6. Grischke, Eva-Maria
   7. Braun, Michael

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer

   1. Grote, Isabel
   2. Bartels, Stephan
   3. Kandt, Leonie
   4. Bollmann, Laura
   5. Christgen, Henriette
   6. Gronewold, Malte
   7. Raap, Mieke

   2021 - Forschungsinformationssystem des UKE - frei zugänglich